CP-96021

Overview

CP-96021 is an orally active dual leukotriene D4 ( LTD4 ) and platelet activating factor ( PAF ) receptor antagonist, featuring a guinea pig LTD4 receptor K i of 34 nM and a rabbit PAF receptor K i of 37 nM. CP-96021 blocks ligand binding to its target receptors, inhibits ligand-induced bronchoconstriction, and inhibits antigen-triggered airway obstructive effects. CP-96021 can be used for the research of asthma.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lower Respiratory Inflammation | Products > Disease Areas > Respiratory Inflammation | Products > Disease Areas > Asthma | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Platelet-activating Factor Receptor (PAFR) | Products > Signaling Pathways > Leukotriene Receptor

Product Information

• Catalog No.: HY-163101
• CAS No.: 139401-43-7
• Molecular Formula: C29H21FN4OS
• Molecular Weight: 492.57
• Purity: 98.04%
• Storage: 4°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (5.08 mM); Clear solution
• Availability: In-stock

Source

Original product source